- Dividend Yield
- 3.25%
- Track Record
- 49 Years of Consecutive Dividend Growth
- Payout Ratio
- 77.3%
- Consensus Rating
- Moderate Buy
- Consensus Price Target
- $97.87 (14.2% Upside)
About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
More about Medtronic